Further experience with hexamethylmelamine (NSC-13875) in the treatment of carcinoma of the cervix.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004123:Dimethylamines / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D014227:Triazines / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004123:Dimethylamines; D014227:Triazines